TP53 and cancer: It is therefore tempting to speculate that HPV‐16 E6, through the coupled inactivation of both p53 and Notch, might confer a similar competitive phenotype to infected cells (Figure 6B), a condition particularly relevant in abortive infections, as well as HPV‐driven cancers where E6 levels are thought to increase 4 (Figure 6B).